2023-03-08 08:36:27 ET
- Fresh Tracks Therapeutics ( FRTX ) +83% on announcing positive topline results from single and multiple ascending dose parts of phase 1 study of Oral DYRK1A Inhibitor FRTX-02.
- Kimball International ( KBAL ) +75% HNI to acquire Kimball in $485M cash and stock transaction.
- Diversey Holdings ( DSEY ) +37% to be acquired by Solenis for $4.6B, stock pops in early trade.
- Rigel Pharmaceuticals ( RIGL ) +32% on FY earnings.
- OPKO Health's ( OPK ) +25% ModeX Therapeutics enters into exclusive worldwide license and collaboration agreement with Merck to develop Epstein-Barr Virus vaccine candidate
- Maxeon Solar Technologies ( MAXN ) +20% on Q4 earnings.
- LifeStance Health Group ( LFST ) +16% on Q4 earnings.
- Zymeworks ( ZYME ) +12% on Q4 earnings.
- Mesoblast ( MESO ) +11% on getting FDA review of graft versus host disease therapy.
- Gol Linhas ( GOL ) +11% on Q4 earnings.
- WeWork ( WE ) +8% said to be in talks to overhaul over $3B of debt, raise more cash.
- Edible Garden ( EDBL ) +8% .
- AMTD Digital ( HKD ) +7% .
- Clene ( CLNN ) +6% .
- Magic Empire Global ( MEGL ) +6% .
- Qualigen Therapeutics ( QLGN ) +6% on data on potential biomarker for its lead program QN-302 published in peer-reviewed journal molecules.
- CrowdStrike Holdings ( CRWD ) +5% on Q4 earnings.
For further details see:
OPK, FRTX and QLGN among pre market gainers